EDWARDS LIFESCIENCES, LLC for EDWARDS LIFESCIENCES LLC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act Innovation Promotion Act of 2015 (Boustany Innovation/Patent Box Leg) H.R. 1, Tax Reform Act of 2014 Obama Administration 2016 Budget Proposals Senate Finance Committee Tax Reform Process
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BARRY ROBERT LIDEN | — |
Health Issues HCR
Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative H.R. 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BARRY ROBERT LIDEN | — |
Medicare/Medicaid MMM
CMS Coverage Policies For Medical Devices CMS Payment Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BARRY ROBERT LIDEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.